Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[S,S]-Reboxetine Extension in PHN
NCT00353808Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of reboxetine in postherpetic neuralgia (PHN), sponsored by Pfizer. Primary endpoints: Vital signs, Physical examination and 3 more. Started Jul 2006; status: terminated.
02
Drugs
reboxetine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00353808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353808.